The shares of Unichem Laboratories Limited were trading higher today by 3 per cent intraday after the company announced that it has received tentative approval from United States Food & Drug Administration (USFDA) for Aripiprazole tablets in the strengths of 2 mg, 5 mg, 10 mg, 15 mg, 20 mg and 30 mg.